Similar articles for PMID: 23862981

Year	Number of Results
2002	1
2010	1
2011	16
2012	41
2013	31
2014	28
2015	27
2016	13
2017	12
2018	10
2019	6
2020	12
2021	8
2022	9
2023	2
2024	0

1

Ipilimumab and vemurafenib: two different routes for targeting melanoma.

Burgeiro A, Mollinedo F, Oliveira PJ. Burgeiro A, et al. Curr Cancer Drug Targets. 2013 Oct;13(8):879-94. doi: 10.2174/15680096113139990080. Curr Cancer Drug Targets. 2013. PMID: 23862981 Review.

2

Vemurafenib and ipilimumab: new agents for metastatic melanoma.

Banaszynski M, Kolesar JM. Banaszynski M, et al. Am J Health Syst Pharm. 2013 Jul 15;70(14):1205-10. doi: 10.2146/ajhp120260. Am J Health Syst Pharm. 2013. PMID: 23820456 Review.

3

Vemurafenib for the treatment of melanoma.

Jordan EJ, Kelly CM. Jordan EJ, et al. Expert Opin Pharmacother. 2012 Dec;13(17):2533-43. doi: 10.1517/14656566.2012.737780. Epub 2012 Oct 24. Expert Opin Pharmacother. 2012. PMID: 23094782 Review.

4

Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue".

Jarkowski A 3rd, Norris L, Trinh VA. Jarkowski A 3rd, et al. Ann Pharmacother. 2014 Nov;48(11):1456-68. doi: 10.1177/1060028014544165. Epub 2014 Jul 23. Ann Pharmacother. 2014. PMID: 25056920 Review.

5

Current and future roles of targeted therapy and immunotherapy in advanced melanoma.

Olszanski AJ. Olszanski AJ. J Manag Care Spec Pharm. 2014 Apr;20(4):346-56. doi: 10.18553/jmcp.2014.20.4.346. J Manag Care Spec Pharm. 2014. PMID: 24684639 Free PMC article. Review.

6

Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma.

Heakal Y, Kester M, Savage S. Heakal Y, et al. Ann Pharmacother. 2011 Nov;45(11):1399-405. doi: 10.1345/aph.1Q363. Epub 2011 Oct 25. Ann Pharmacother. 2011. PMID: 22028422 Review.

7

Vemurafenib for the treatment of BRAF mutant metastatic melanoma.

Martin-Liberal J, Larkin J. Martin-Liberal J, et al. Future Oncol. 2015;11(4):579-89. doi: 10.2217/fon.14.252. Future Oncol. 2015. PMID: 25686114 Review.

8

How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma.

Wolchok J. Wolchok J. Ann Oncol. 2012 Sep;23 Suppl 8(Suppl 8):viii15-21. doi: 10.1093/annonc/mds258. Ann Oncol. 2012. PMID: 22918923 Free PMC article. Review.

9

Cutaneous melanoma: new advances in treatment.

Foletto MC, Haas SE. Foletto MC, et al. An Bras Dermatol. 2014 Mar-Apr;89(2):301-10. doi: 10.1590/abd1806-4841.20142540. An Bras Dermatol. 2014. PMID: 24770508 Free PMC article. Review.

10

[Major therapeutic advances in the treatment of metastatic melanoma].

Mateus C, Robert C. Mateus C, et al. Bull Cancer. 2012 Jun;99(6):619-25. doi: 10.1684/bdc.2012.1594. Bull Cancer. 2012. PMID: 22652330 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

200 results

Results by year